We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OZYMF market cap is 3.18M. The company's latest EPS is DKK 738.2759 and P/E is 0.12.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 0 | 0 | 0 | 36.19M | 17.87M |
| Operating Income | -231.65M | -335.95M | -608.53M | -633.3M | -119.55M |
| Net Income | -229.6M | -337.5M | -633.25M | -626.54M | 26.07M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 441.35M | 180.75M | 822.49M | 173.23M | 58.12M |
| Total Liabilities | 53.1M | 127.79M | 201.97M | 163.89M | 16.46M |
| Total Equity | 388.25M | 52.97M | 620.53M | 9.34M | 41.67M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | -234.76M | -326.82M | -539.08M | -602.57M | -117.95M |
| Investing | -2.35M | -3.29M | -5.1M | 46k | 90.35M |
| Financing | N/A | 58.94M | 1.16B | -30.34M | -35.08M |
| Market Cap | 3.18M |
| Price to Earnings Ratio | 0.12 |
| Price to Sales Ratio | 0.18 |
| Price to Cash Ratio | 0.07 |
| Price to Book Ratio | 0.08 |
| Dividend Yield | - |
| Shares Outstanding | 35.31k |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -40.00% |
| 52 Week High | 150.00 |
| 52 Week Low | 0.001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Orphazyme A S (CE) |
| Address |
ole maal��es vej 3 copenhagen DK-2200 |
| Website | https://www.orphazyme.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
